Related Experiment Videos
[Isolated systolic hypertension in the aged]
V Marigliano1, F Campana, I Trani
1Cattedra di Gerontologia e Geriatria, Università La Sapienza, Roma. marigliano@uniroma1.it
Recenti Progressi in Medicina
|April 14, 2000
Summary
Isolated systolic hypertension (ISH) is an age-related condition and a significant risk factor for stroke and other disabling diseases. Drug therapy effectively lowers blood pressure and prevents related cardiovascular events.
Area of Science:
- Gerontology and Cardiovascular Medicine
- Epidemiology of Chronic Diseases
Context:
- Isolated systolic hypertension (ISH) prevalence increases with age, posing a significant public health challenge.
- Demographic shifts have amplified the importance of ISH as a risk factor for major diseases like stroke.
- Current hypertension diagnostic criteria may lead to underestimation of the true prevalence of ISH.
Purpose:
- To highlight the epidemiological significance of isolated systolic hypertension (ISH).
- To underscore the role of ISH as a primary risk factor for severe health outcomes.
- To review the established efficacy of pharmacological interventions for managing ISH.
Summary:
- Epidemiological data confirm ISH as a critical risk factor for mortality and cardiovascular/cerebrovascular events.
- Clinical trials demonstrate that antihypertensive drug therapy is effective in reducing blood pressure.
- Treatment significantly lowers the incidence of fatal and non-fatal events associated with ISH.
Impact:
- Provides evidence for targeted interventions and treatment strategies for ISH.
- Informs public health policies regarding hypertension management in aging populations.
- Reinforces the importance of pharmacological treatment in mitigating ISH-related morbidity and mortality.